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176a Sunday, March 1, 2009KCNQ3 genes. Dorsal root ganglia (DRG) neurons cultured in the presence of
a REST-expressing adenovirus showed 7.3950.11 fold (p%0.05) increased
REST protein, which led to a concomitant 2.2050.09 fold (p%0.05) decrease
in KCNQ2 protein and a corresponding 7.6550.49 fold (p%0.01) reduction in
M-current in DRG neurons, compared to vehicle control. We further show that
REST protein expression was increased 3.6550.80 fold in cultured DRG neu-
rons in response to inflammatory stimulation (1 mM bradykinin, 1 mM hista-
mine, 1 mMATP, 10 mMPAR2-AP and 1 mM substance P for 48 hrs). Increases
in REST correlated with a 1.7650.38 (p%0.05) fold decrease in KCNQ2 im-
munoreactivity. Similarly we observed a significant increase in REST mRNA
(2.1150.01 fold) and protein levels and a reciprocal downregulation of
KCNQ2 (1.7550.07 fold) and KCNQ3 (1.4350.01 fold) transcripts in
DRGs from animals with neuropathic nerve injury (partial sciatic nerve lesion,
PSNL).We propose that transcriptional regulation of KCNQ channels by REST
will have profound effects on neuronal excitability and may contribute to the
mechanisms of peripheral sensitisation in chronic pain.Voltage-gated K Channels - Permeation
909-Pos Board B788
Permeation And Conformational Changes Of The Pore Domain Of The
Kv1.2 Potassium Channel
Mortenø Jensen1, David W. Borhani1, Ron O. Dror1, Michael P. Eastwood1,
Kresten Lindorff-Larsen1, Paul Maragakis1, David E. Shaw1,2.
1D. E. Shaw Research, New York, NY, USA, 2Center for Computational
Biology and Bioinformatics, Columbia University, New York, NY, USA.
We have computationally determined the conductance of the pore-domain of the
Kv1.2 potassium channel under physiologically relevant conditions of driving
force and ion concentration using microsecond-timescale all-atom molecular
dynamics simulations. The conductance, found to be limited in part by the rate
of dehydration of the ion, is close to the experimental value for intact Kv1.2.
Wefind thatwater and potassium ions are co-transported in a stoichiometric ratio
close to one, as previously hypothesized, yet water and potassium favor different
positionswithin the selectivity filter of the pore. On amicrosecond timescale, the
open conducting pore domain is found to undergo substantial conformational
changes causing current attenuation, likely related to channel inactivation
from the extracellular side. Finally, we observe reproducible closure events of
the pore domain that involve pronounced conformational changes of the S6
and S4-S5 linker helices and of cavity-lining residues, whose net effect is to re-
duce hydration of the cavity and thus prevent its occupation by potassium ions.
910-Pos Board B789
Mapping the Binding Site of the Alkoxypsoralen PAP-1 in the Voltage-
Gated Kþ Channel Kv1.3
Pavel I. Zimin1, Bojan Garic2, Heike Wulff1, Boris S. Zhorov2.
1UC Davis, Davis, CA, USA, 2McMaster University, Hamilton, ON, Canada.
Kv1.3 is widely regarded as an attractive drug target for the treatment of effector
memory T cell-mediated autoimmune diseases such as multiple sclerosis, type-1
diabetes and psoriasis. Schmitz et al. (2005) identified 5-(4-phenoxybutoxy)psor-
alen (PAP-1) as a potent and selective small molecule Kv1.3 blocker. Unlike the
classical Kv1 blocker tetraethylammonium, the nucleophilic PAP-1 blocks
Kv1.3 with a 2:1 stoichiometry. Following a hypothesis that nucleophilic ligands
can coordinate a metal ion in the channel pore, we usedMonte Carlo-energymin-
imizations to search for possible complexes of two PAP-1 ligandswith a Kþ ion in
the Kv1.2-based model of Kv1.3. In a predicted complex, the furocoumarin moi-
eties of two ligands chelate a Kþ ion at the focus of the P-helices in the central cav-
ity, while the 4-phenoxybutoxy arms extend into the intrasubunit S5/S6 interfaces
and reach the S4-S5 linkers. The model predicted ligand-sensing residues in the
S4-S5 linker, S5, P-loop, and S6. We next tested the model by introducing single
amino acid substitutions intoKv1.3 and exploring the biophysical properties of the
mutants and their sensitivity to PAP-1 in whole-cell patch-clamp experiments. So
farwe have confirmedL335 in the S4-S5 linker, L353 inS5, andV417 andT419 in
S6 as PAP-1 sensing residues. Among the mutants, V417L exhibited the largest
change in IC50, 400 nM versus 2 nM for the wild-type channel. Interestingly,
V417L and T419A also exhibit more of an open-channel type block rather than
a C-type inactivated state block. The proposed model explains the actions of var-
ious nucleophilic ligands thatblockcationic channelswithaHill coefficient greater
than 1, opening a new direction for structure-based design of ion channel drugs.
Supported by CIHR, NIH, and HHMI.
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University of British Columbia, Vancouver, BC, Canada.Vernakalant (RSD1235) is an investigational drug recently shown to convert
atrial fibrillation rapidly and safely in patients as an intravenous formulation
(Roy et al., 2004) and to maintain sinus rhythm when taken orally (Savelieva
and Camm, 2008). In the present study, the modeling software AutoDock4
was used to explore potential binding modes of vernakalant to the open state
of the Kv1.2 model, which is 100% homologous in the binding region with
Kv1.5. Docking simulations were run with a maximum number of evaluations
of 25,000,000 and a maximum number of generations of 27,000. Point muta-
tions were made in the channel model based on earlier patch-clamp studies
(Eldstrom et al., 2007) and the docking simulations re-run to evaluate the abil-
ity of the docking software to predict changes in drug-channel interactions.
Each AutoDock run predicted a binding conformation with an associated value
for free energy of binding (FEB) in kcal/mol and an estimated inhibitory con-
centration (Ki). Increasing the number of evaluations and thus the time allowed
for the program to look for an optimal binding site decreased average FEB and
Ki values, and resulted in two front runner binding conformations. The most
favored conformation had a FEB of -7.12 kcal/mol and a predicted Ki of
6.08 mM. This conformation makes contact with all four T480 residues and
when examined from the side view and from above appears to be clearly posi-
tioned to block the channel as it directly occludes the pore.
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Surface expression of voltage-dependent Kþ channels (Kv) has a pivotal role in
leukocyte physiology. Although little is known about the physiological role of
lipid rafts, these microdomains concentrate signaling molecules and their ion
channel substrates. Kv1.3 associates with Kv1.5 to form functional channels
in macrophages. Different isoform stoichiometries lead to distinct heteromeric
channels which may be further modulated by targeting the complex to different
membrane surface microdomains. Kv1.3 targets to lipid rafts, whereas Kv1.5
localization is under debate. With this in mind, we wanted to study whether het-
erotetrameric Kv1.5-containing channels target to lipid rafts. While in trans-
fected HEK-293 cells, homo- and heterotetrameric channels targeted to rafts,
Kv1.5 did not target to rafts in macrophages. Therefore, Kv1.3/Kv1.5 hybrid
channels are mostly concentrated in non-raft microdomains. However, LPS-in-
duced activation, which increases the Kv1.3/Kv1.5 ratio and caveolin, targeted
Kv1.5 back to lipid rafts. Moreover, Kv1.5 did not localize to low-buoyancy
fractions in L6E9 skeletal myoblasts, which also coexpress both channels, heart
membranes or cardiomyocyes. Coexpression of a Cav3DGV-mutant confined
Kv1.5 to Cav3DGV-vesicles of HEK cells. Contrarily, coexpression of
Kvb2.1 impaired the Kv1.5 targeting to raft microdomains in HEK cells. Our
results indicate that Kv1.5 partnership interactions are underlying mechanisms
governing channel targeting to lipid rafts.
Supported by BFU2005-695, BFU2008-00431 and CSD2008-00005 Ministerio
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Ion channels are a key target class with a high therapeutic potential. Conven-
tional screening techniques yield insufficient data quality particularly when as-
sessing voltage-gated ion channels. Thus, the development of new reliable
technologies is desirable to integrate ion channel screening into early lead gen-
eration of drug discovery.
Here we demonstrate a method that allows non-invasive, millisecond light-
induced activation of voltage-gated ion channels and the concurrent imaging
of membrane potential changes using fast voltage-sensitive dyes. This light-in-
duced voltage clamp method (LIVC) uses photostimulation through channelr-
hodopsin-2 (ChR2), to activate voltage-gated ion channels. ChR2 allows blue
light (~ 470 nm) to be immediately transduced into a depolarizing ionic current,
which causes voltage-gated ion channels to open. We coexpressed ChR2 with
the voltage-gated potassium channel hKv1.5 in HEK293 cells and in Xenopus
oocytes. In electrophysiological experiments we show that the light-induced
cell depolarization through ChR2 sufficed to open hKv1.5 channels; the
light-induced membrane depolarization was greatly reduced with active
hKv1.5 channels compared to the full ChR2 response during hKv1.5 inhibition.
